Is There a Real Export Business in Thai Cannabis?
There is a real but limited legal export business in Thai cannabis, and it is much smaller than the ambition around it. Certification barriers, above all the lack of EU-GMP, keep Thailand out of the largest medical markets, so legal export operates at modest scale into markets Thailand can actually access. A genuine export business exists; a large-scale one does not, at least not until the certification gap closes.
Where legal export can go
Legal export is possible where the destination market's requirements can be met and Thai authorization is in place. That is a narrower set of markets and volumes than the bullish case assumes, because the most valuable regulated markets demand certifications Thailand largely lacks. The realistic export business is a modest, specialized one, not a commodity flood.
The barrier that defines it
The defining barrier is certification. EU-GMP for Europe, and comparable standards elsewhere, gate access. Until Thai producers invest in clearing those bars, the export business stays small. This is why the honest export opportunity is a certification-and-access question first, and a cultivation question a distant second.
The realistic opportunity
For an investor, the real export opportunity may lie in building toward certification rather than assuming market access exists today. That is a long, capital-intensive play with a specific thesis, not a quick win. Distinguishing the modest real export business from the inflated one, and sizing the genuine opportunity, is the kind of analysis our report provides.
Yes, but limited and much smaller than claimed.
Certification barriers, especially EU-GMP.
Markets whose requirements it can meet, which are fewer.
Potentially building toward certification, a long-term play.
This post gives you the argument. The full method, the figures, and the confidence ratings behind them are in the report. Read a free sample chapter, then decide.
Read the free sample →